These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4703824)

  • 1. Physiological disposition and metabolism of levo-methadone-1- 3 H in nontolerant and tolerant rats.
    Misra AL; Mulé SJ; Bloch R; Vadlamani NL
    J Pharmacol Exp Ther; 1973 May; 185(2):287-99. PubMed ID: 4703824
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiological disposition and biotransformation of levo-methandone-1-3H in the dog.
    Misra AL; Bloch R; Vadlamani NL; Mulé SJ
    J Pharmacol Exp Ther; 1974 Jan; 188(1):34-44. PubMed ID: 4809275
    [No Abstract]   [Full Text] [Related]  

  • 3. Stereoselectivity and differential metabolism in vivo of dextro and laevo-methadone-1- 3 H.
    Misra AL; Mulè SJ
    Nature; 1973 Jan; 241(5387):281-3. PubMed ID: 4550034
    [No Abstract]   [Full Text] [Related]  

  • 4. Laeve-[1-3H]Methadone disposition in tolerant dogs.
    Misra AL; Bloch R; Vadlamani NL; Mulé SJ
    Xenobiotica; 1975 Apr; 5(4):237-44. PubMed ID: 1154803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and plasma levels of methadone and their relationships to analgesic activity of methadone in rats.
    Liu SJ; Roerig DL; Wang RI
    Drug Metab Dispos; 1983; 11(4):335-8. PubMed ID: 6137339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of urinary excretion of methadone metabolites with methadone metabolism and analgesia in the rat.
    Liu SJ; Evans DB; Wang RI
    J Pharmacol Exp Ther; 1978 Jan; 204(1):67-76. PubMed ID: 619136
    [No Abstract]   [Full Text] [Related]  

  • 7. Biliary and urinary elimination of methadone and its metabolites in the rat.
    Baselt RC; Casarett LJ
    Biochem Pharmacol; 1972 Oct; 21(20):2704-12. PubMed ID: 4647078
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of diazepam, desmethylimipramine, and SKF 525-A on the disposition of levo-methadone in mice after single or double injection.
    Shah NS; Patel VO; Donald AG
    Drug Metab Dispos; 1979; 7(4):241-2. PubMed ID: 39728
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of methadone-3H and metabolite in rat brain after a single injection and its implications on pharmacological tolerance.
    Misra AL; Mulé SJ
    Nature; 1972 Jul; 238(5360):155-7. PubMed ID: 4558456
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved thin-layer chromatography system for methadone and its metabolites in biological samples.
    Davis CM; Fenimore DC
    J Chromatogr; 1975 Jan; 104(1):193-5. PubMed ID: 166082
    [No Abstract]   [Full Text] [Related]  

  • 11. Physiologic disposition and metabolism of (3H) ecgonine (cocaine metabolite) in the rat.
    Misra AL; Vadlamani NL; Bloch R; Nayak PK; Mule SJ
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):55-63. PubMed ID: 4847905
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromatographic separation of methadone, some of its metabolites and congeners.
    Misra AL; Vadlamani NL; Mule SJ
    J Chromatogr; 1972 May; 67(2):379-81. PubMed ID: 5030904
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats.
    Garrido MJ; Valle M; Calvo R; Trocóniz IF
    J Pharmacol Exp Ther; 1999 Jan; 288(1):179-87. PubMed ID: 9862769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of methadone in man.
    Robinson AE; Williams FM
    J Pharm Pharmacol; 1971 May; 23(5):353-8. PubMed ID: 4396979
    [No Abstract]   [Full Text] [Related]  

  • 15. Thin-layer chromatographic separation of methadone and its primary metabolite in the presence of other drugs in urine specimens.
    Jain NC; Leung WJ; Budd RD; Sneath TC
    J Chromatogr; 1975 Jan; 103(1):85-90. PubMed ID: 1117043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of 3H-cyclazocine in dogs.
    Mulé SJ; Gorodetzky CW; Clements TH
    Adv Biochem Psychopharmacol; 1973; 8(0):503-23. PubMed ID: 4794906
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative determination of methadone concentrations in human blood, plasma and urine by gas chromatography.
    Sullivan HR; Blake DA
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):467-78. PubMed ID: 5034508
    [No Abstract]   [Full Text] [Related]  

  • 18. [Permeation of active morphine-like substances at their sites of antinociceptive action in the brain as a function of their lipid-solubility following intravenous and intraventricular application].
    von Cube B; Teschemacher H; Herz A; Hess R
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 265(5):455-73. PubMed ID: 4190489
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolism of alpha-dl-acetylmethadol in the rat: the identification of the probable active metabolite.
    McMahon RE; Culp HW; Marshall FJ
    J Pharmacol Exp Ther; 1965 Sep; 149(3):436-45. PubMed ID: 5848054
    [No Abstract]   [Full Text] [Related]  

  • 20. The difference in activity between (+)- and (-)-methadone is intrinsic and not due to a difference in metabolism.
    Sullivan HR; Due SL; McMahon RE
    J Pharm Pharmacol; 1975 Oct; 27(10):728-32. PubMed ID: 241784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.